Page 6 - Urovant Sciences News Today

Athira Pharma's CEO resigns after investigation confirms she altered research during graduate school. vTv Therapeutics named healthcare investor Deepa Prasad its new CEO and president. Opus Genetics snagged a new chief scientific officer and chief operating officer.

Data from the dedicated, stand-alone, ambulatory blood pressure trial will be the focus of a podium presentation Efficacy in patients with 'dry' overactive bladder, based on a post-hoc analysis

Urovant Sciences, Inc., a wholly-owned subsidiary of Sumitovant Biopharma Ltd., today announced the appointment of Betzy Estrada as executive vice president and chief human resources officer. In her

Xtalks Announces Its Life Science Webinar Calendar for June 2021 Share Article Upcoming free, educational webinars from Xtalks Webinars will feature topics on biomarkers, clinical trials, drug discovery & development, healthcare, laboratory technology, patient recruitment & retention, pharmaceutical, pharma manufacturing & supply chain, medical devices and food. TORONTO (PRWEB) June 01, 2021 Stay on top of current hot topics throu...

/PRNewswire/ -- Sumitovant Biopharma, Inc. today announced that its portfolio of four wholly owned subsidiary companies (Urovant, Enzyvant, Altavant and...

Toronto, ON (PRWEB) May 25, 2021 -- Clinical development has more partnerships and collaborations than ever before with many companies acquiring assets from

NEW YORK, May 14, 2021 /PRNewswire/ -- PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, today announced the winners of

(1) Vancouver, British Columbia--(Newsfile Corp. - May 4, 2021) - Alpha Cognition Inc. (TSXV: ACOG) ("Alpha Cognition", or the "Company"), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, is pleased to announce the appointment of Lauren DAngelo to Chief Commercial Officer. In this role, she will ensure the integrated commercial success of the company. Her initial focus will be ...

Erectile Dysfunction Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working in the Space iCrowd Newswire DelveInsights Erectile Dysfunction market report overview of pathophysiology, various diagnostic approaches, and treatment algorithm, including detailed chapters for marketed products and emerging therapies DelveInsights " Some of the key highlights from the A more extensive national study, the National Health and Social Life Survey, looked at sexual function survey...

Vancouver, British Columbia–(Newsfile Corp. – May 4, 2021) – Alpha Cognition Inc. (TSXV: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, is pleased to announce the appointment of Lauren D’Angelo to Chief Commercial Officer. In this role, she will ensure the integrated commercial success of the company. Her initial fo...